希达罗治疗晚期消化道肿瘤43例疗效观察(论著)

希达罗治疗晚期消化道肿瘤43例疗效观察(2)

http://www.100md.com 2009年8月1日《社区医学杂志》 2009年第15期

     \[2\] 储大同,刘基巍,李维廉,等.希罗达治疗转移性乳腺癌的疗效和安全性的临床研究\[J\].临床肿瘤学杂志,2003,8(5):321-324.

    \[3\] Ishikawa T,Utoh M,Sawada N,et al.Capecitabine,a new oral fluoropyrimidine carbamate,selectively delivers fluorouracil tl tumor tissues in human cancer xenlgrafts\[J\].Biochem Pharmacol,1998,55(3):1091-1097.

    \[4\] Schuller J,Dumont E.Preferential activate lf capecitabine in tumor following oral administration to colorectal patient\[J\].Cancer Chemothen Pharmacol,2000,45:291-297.

    \[5\] Reichardt P,Von Minckwitz G,Thuss-Patience PC,et al,Multicenter phade Ⅱ study of oral capecitabine(Xeloda) in patients with metastatic bieast cancer relapsing after treatment with a taxane-containing theory\[J\].Ann oncol,2003,14:1227-1233. ......

上一页第 1 2 页

百拇医药网 http://www.100md.com/html/paper/1672-4208/2009/15/08-1.htm

您现在查看是摘要页，全文长 4919 字符。